Recro Pharma (REPH) Added To Russell Microcap® Index
6/30/2014 7:55:26 AM
MALVERN, Pa., June 30, 2014 (GLOBE NEWSWIRE) -- Recro Pharma, Inc. (Nasdaq:REPH), a clinical stage specialty pharmaceutical company developing non-opioid therapeutics for the treatment of pain, initially for acute pain following surgery, today announced that it was added to the Russell Microcap® Index following market close on June 27, 2014.
Help employers find you! Check out all the jobs and post your resume.
comments powered by